BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Turner D, Hyams J, Markowitz J, Lerer T, Mack DR, Evans J, Pfefferkorn M, Rosh J, Kay M, Crandall W, Keljo D, Otley AR, Kugathasan S, Carvalho R, Oliva-Hemker M, Langton C, Mamula P, Bousvaros A, LeLeiko N, Griffiths AM; Pediatric IBD Collaborative Research Group. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis 2009;15:1218-23. [PMID: 19161178 DOI: 10.1002/ibd.20867] [Cited by in Crossref: 181] [Cited by in F6Publishing: 126] [Article Influence: 12.9] [Reference Citation Analysis]
Number Citing Articles
1 Bashir NS, Walters TD, Griffiths AM, Otley A, Critch J, Ungar WJ. A Comparison of Preference-Based, Generic and Disease-Specific Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology 2023. [DOI: 10.1093/jcag/gwac034] [Reference Citation Analysis]
2 Liao HT(. Paris Classification of inflammatory bowel disease. Radiopaedia.org 2023. [DOI: 10.53347/rid-159420] [Reference Citation Analysis]
3 Gamwell KL, Roberts CM, Kraft JD, Edwards CS, Baudino MN, Grunow JE, Jacobs NJ, Tung J, Mullins LL, Chaney JM. Factor analysis of the stigma scale-child in pediatric inflammatory bowel disease. J Psychosom Res 2023;164:111095. [PMID: 36495755 DOI: 10.1016/j.jpsychores.2022.111095] [Reference Citation Analysis]
4 Marcovitch L, Focht G, Carmon N, Tersigni C, Ledder O, Lev-Tzion R, Church PC, Hyams J, Baldassano R, Bousvaros A, Mack DR, Hussey S, Otley A, Croft NM, Kappelman MD, Griffiths AM, Turner D. Development and Validation of the TUMMY-UC: A Patient-Reported Outcome for Pediatric Ulcerative Colitis. Gastroenterology 2022:S0016-5085(22)01390-7. [PMID: 36539016 DOI: 10.1053/j.gastro.2022.12.006] [Reference Citation Analysis]
5 Lee WS, Arai K, Alex G, Treepongkaruna S, Kim KM, Choong CL, Mercado KC, Darma A, Srivastava A, Aw MM; APPSPGHAN PIBD Working Group. Management and monitoring of pediatric inflammatory bowel disease in the Asia-Pacific region: A position paper by the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management, disease monitoring, and special considerations. J Gastroenterol Hepatol 2022. [PMID: 36508314 DOI: 10.1111/jgh.16084] [Reference Citation Analysis]
6 Nasab AS, Finkler M, Delozier S, Sferra TJ, Splawski J, Moses J. Comparison of Short-Term Outcomes for Standard Versus Nonstandard Induction Dosing of Infliximab for Pediatric Inflammatory Bowel Disease. The Journal of Pediatric Pharmacology and Therapeutics 2022;27:732-738. [DOI: 10.5863/1551-6776-27.7.732] [Reference Citation Analysis]
7 Ivana Trivić, Sara Sila, Zrinjka Mišak, Tena Niseteo, Ana Tripalo Batoš, Iva Hojsak, Sanja Kolaček. Impact of an exercise program in children with inflammatory bowel disease in remission. Pediatr Res 2022. [PMID: 36319697 DOI: 10.1038/s41390-022-02362-8] [Reference Citation Analysis]
8 Colman RJ, Mizuno T, Fukushima K, Haslam DB, Hyams JS, Boyle B, Noe JD, D'Haens GR, Van Limbergen J, Chun K, Yang J, Denson LA, Ollberding NJ, Vinks AA, Minar P. Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance. Aliment Pharmacol Ther 2022. [PMID: 36314265 DOI: 10.1111/apt.17277] [Reference Citation Analysis]
9 Martin NG, Roberts AJ, Evans HM, Bishop J, Day AS. Adherence to the New Zealand Pediatric Guideline for the Assessment and Diagnosis of Inflammatory Bowel Disease. JPGN Reports 2022;3:e266. [DOI: 10.1097/pg9.0000000000000266] [Reference Citation Analysis]
10 Buczyńska A, Grzybowska-Chlebowczyk U. Prognostic Factors of Biologic Therapy in Pediatric IBD. Children (Basel) 2022;9:1558. [PMID: 36291494 DOI: 10.3390/children9101558] [Reference Citation Analysis]
11 Nyström N, Prast-Nielsen S, Correia M, Globisch D, Engstrand L, Schuppe Koistinen I, Halfvarson J. Mucosal and plasma metabolomes in new-onset paediatric inflammatory bowel disease: correlations with disease characteristics and plasma inflammation protein markers. J Crohns Colitis 2022:jjac149. [PMID: 36219554 DOI: 10.1093/ecco-jcc/jjac149] [Reference Citation Analysis]
12 Penagini F, Calcaterra V, Dilillo D, Vandoni M, Gianolio L, Gatti A, Rendo G, Giuriato M, Cococcioni L, De Silvestri A, Zuccotti G. Self-Perceived Physical Level and Fitness Performance in Children and Adolescents with Inflammatory Bowel Disease. Children 2022;9:1399. [DOI: 10.3390/children9091399] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Edwards CS, Roberts CM, Baudino MN, Basile NL, Gamwell KL, Jacobs NJ, Tung J, Grunow JE, Mullins LL, Chaney JM. The Combined Effects of Youth and Parent Illness Intrusiveness on Depressive Symptoms in Adolescents with Inflammatory Bowel Disease. J Clin Psychol Med Settings 2022. [PMID: 35668287 DOI: 10.1007/s10880-022-09886-5] [Reference Citation Analysis]
14 Ninh G, Kallemose T, Wewer V, Jakobsen C. Incidence, Disease Course, and Medical Treatment of a Danish Population-Based Cohort of Very Early-Onset Inflammatory Bowel Disease. GastroHep 2022;2022:1-11. [DOI: 10.1155/2022/3507028] [Reference Citation Analysis]
15 Huang JG, Wong YKY, Chew KS, Tanpowpong P, Calixto Mercado KS, Reodica A, Rajindrajith S, Chang KC, Ni YH, Treepongkaruna S, Lee WS, Aw MM. Epidemiological characteristics of Asian children with inflammatory bowel disease at diagnosis: Insights from an Asian-Pacific multi-centre registry network. World J Gastroenterol 2022; 28(17): 1830-1844 [PMID: 35633913 DOI: 10.3748/wjg.v28.i17.1830] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Usoltseva OV, Surkov AN, Potapov AS, Movsisyan GB, Chernikov VV. Association of autoimmune hepatobiliary pathology with inflammatory bowel diseases in children. RPJ 2022;25:106-115. [DOI: 10.46563/1560-9561-2022-25-2-106-115] [Reference Citation Analysis]
17 Karaskova E, Kubickova V, Velganova-veghova M, Geryk M, Foltenova H, Karasek D. Circulating Levels of WISP-1 (Wnt1-Inducible Signaling Pathway Protein 1) and Other Selected Adipokines in Children With Inflammatory Bowel Disease. Physiol Res 2022. [DOI: 10.33549/physiolres.934854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gordon RJ, Wells R, Johansen C, Liu S, Dahlberg SE, Snapper SB, Rufo PA. Efficacy and Safety of High-dose Cholecalciferol in Patients With Inflammatory Bowel Disease Receiving Infliximab. J Pediatr Gastroenterol Nutr 2022;74:476-83. [PMID: 35045559 DOI: 10.1097/MPG.0000000000003386] [Reference Citation Analysis]
19 Gerenli N, Sozeri B, Kalin S, Kirmizibekmez H, Celtik C. Sacroiliac joint involvement in children with inflammatory bowel diseases. North Clin Istanb 2022;9:57-63. [PMID: 35340318 DOI: 10.14744/nci.2021.24572] [Reference Citation Analysis]
20 El Amrousy D, Elashry H, Salamah A, Maher S, Abd-elsalam SM, Hasan S. Adherence to the Mediterranean Diet Improved Clinical Scores and Inflammatory Markers in Children with Active Inflammatory Bowel Disease: A Randomized Trial. JIR 2022;Volume 15:2075-86. [DOI: 10.2147/jir.s349502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kuloglu Z, Çetin F, Urgancı N, Önal Z, Sarı S, Yüksekkaya H, Çaltepe G, Kutluk G, Dumlupinar E; Turkish Inflammatory Bowel Disease Study Group. Nutritional characteristic of children with inflammatory bowel disease in the nationwide inflammatory bowel disease registry from the Mediterranean region. Eur J Clin Nutr 2022. [PMID: 35173290 DOI: 10.1038/s41430-022-01094-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Usoltseva OV, Surkov AN, Movsisyan GB, Kulebina EA, Simersina SA, Potapov AS, Lokhmatov MM. Primary sclerosing cholangitis in children with inflammatory bowel disease. RPJ 2022;24:395-404. [DOI: 10.46563/1560-9561-2021-24-6-395-404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Bousvaros A. Management of Pediatric Patients Hospitalized with Ulcerative. Management of Inpatient Inflammatory Bowel Disease 2022. [DOI: 10.1007/978-1-0716-1987-2_11] [Reference Citation Analysis]
24 Trivić I, Sila S, Batoš AT, Mišak Z, Kolaček S, Hojsak I. Moderate-to-Vigorous Physical Activity Is Associated With Higher Bone Mineral Density in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2022;74:54-9. [PMID: 34321428 DOI: 10.1097/MPG.0000000000003258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
25 Kishi M, Hirai F, Takatsu N, Hisabe T, Takada Y, Beppu T, Takeuchi K, Naganuma M, Ohtsuka K, Watanabe K, Matsumoto T, Esaki M, Koganei K, Sugita A, Hata K, Futami K, Ajioka Y, Tanabe H, Iwashita A, Shimizu H, Arai K, Suzuki Y, Hisamatsu T. A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation. J Gastroenterol 2022;57:246-66. [PMID: 35235037 DOI: 10.1007/s00535-022-01862-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Wang X, Xiao Y, Xu X, Guo L, Yu Y, Li N, Xu C. Characteristics of Fecal Microbiota and Machine Learning Strategy for Fecal Invasive Biomarkers in Pediatric Inflammatory Bowel Disease. Front Cell Infect Microbiol 2021;11:711884. [PMID: 34950604 DOI: 10.3389/fcimb.2021.711884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Baudino MN, Roberts CM, Edwards CS, Gamwell KL, Tung J, Jacobs NJ, Grunow JE, Chaney JM. The impact of illness intrusiveness and overparenting on depressive symptoms in parents of youth with inflammatory bowel disease. J Spec Pediatr Nurs 2022;27:e12362. [PMID: 34811881 DOI: 10.1111/jspn.12362] [Reference Citation Analysis]
28 El Amrousy D, El Ashry H, Hodeib H, Hassan S. Vitamin D in Children With Inflammatory Bowel Disease: A Randomized Controlled Clinical Trial. J Clin Gastroenterol 2021;55:815-20. [PMID: 33060436 DOI: 10.1097/MCG.0000000000001443] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
29 van Hoeve K, Seyed Tabib NS, Dreesen E, Tops S, Hoffman I, Gils A, Ferrante M, Vermeire S. Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy. J Pediatr 2022;240:150-157.e4. [PMID: 34481805 DOI: 10.1016/j.jpeds.2021.08.079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Starr AE, Deeke SA, Ning Z, de Nanassy J, Singleton R, Benchimol EI, Mack DR, Stintzi A, Figeys D. Associations between Cellular Energy and Pediatric Inflammatory Bowel Disease Patient Response to Treatment. J Proteome Res 2021;20:4393-404. [PMID: 34424714 DOI: 10.1021/acs.jproteome.1c00341] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Adepoju AA, Akere A, Ogun GO, Ogunbosi BO, Asinobi AO, Bello O, Orimadegun AE, Allen S, Akinyinka OO. Co-existing sickle cell anaemia and inflammatory bowel disease: case report and review of the literature. Paediatr Int Child Health 2021;:1-7. [PMID: 34474658 DOI: 10.1080/20469047.2021.1936393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Mo A, Nagpal S, Gettler K, Haritunians T, Giri M, Haberman Y, Karns R, Prince J, Arafat D, Hsu NY, Chuang LS, Argmann C, Kasarskis A, Suarez-Farinas M, Gotman N, Mengesha E, Venkateswaran S, Rufo PA, Baker SS, Sauer CG, Markowitz J, Pfefferkorn MD, Rosh JR, Boyle BM, Mack DR, Baldassano RN, Shah S, LeLeiko NS, Heyman MB, Griffiths AM, Patel AS, Noe JD, Davis Thomas S, Aronow BJ, Walters TD, McGovern DPB, Hyams JS, Kugathasan S, Cho JH, Denson LA, Gibson G. Stratification of risk of progression to colectomy in ulcerative colitis via measured and predicted gene expression. Am J Hum Genet 2021;108:1765-79. [PMID: 34450030 DOI: 10.1016/j.ajhg.2021.07.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Grant A, Lerer T, Griffiths AM, Hyams J, Otley A. Assessing disease activity using the pediatric Crohn’s disease activity index: Can we use subjective or objective parameters alone? World J Gastroenterol 2021; 27(30): 5100-5111 [PMID: 34497438 DOI: 10.3748/wjg.v27.i30.5100] [Reference Citation Analysis]
34 Smyth M, Chan J, Evans K, Penner C, Lakhani A, Newlove T, Jacobson K. Cross-Sectional Analysis of Quality of Life in Pediatric Patients with Inflammatory Bowel Disease in British Columbia, Canada. J Pediatr 2021:S0022-3476(21)00703-4. [PMID: 34293367 DOI: 10.1016/j.jpeds.2021.07.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Zysset D, Montani M, Spalinger J, Schibli S, Zlobec I, Mueller C, Sokollik C. Molecular and Histological Profiling Reveals an Innate-Shaped Immune Microenvironment in Solitary Juvenile Polyps. Clin Transl Gastroenterol 2021;12:e00361. [PMID: 34060497 DOI: 10.14309/ctg.0000000000000361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Maddux M, Gordy A, Schurman C, Cole T, Staggs V. Initial Validation of IBD KNOW-IT: Measuring Patient and Caregiver Knowledge of a Child's Disease and Treatment Regimen. J Clin Psychol Med Settings. 2020;27:480-489. [PMID: 31144222 DOI: 10.1007/s10880-019-09636-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
37 Britto SL, Hoffman KL, Tessier ME, Petrosino J, Miloh T, Kellermayer R. Microbiome Responses to Vancomycin Treatment in a Child With Primary Sclerosing Cholangitis and Ulcerative Colitis. ACG Case Rep J 2021;8:e00577. [PMID: 33997090 DOI: 10.14309/crj.0000000000000577] [Reference Citation Analysis]
38 Bashir NS, Walters TD, Griffiths AM, Ungar WJ. An Assessment of the Validity and Reliability of the Pediatric Child Health Utility 9D in Children with Inflammatory Bowel Disease. Children (Basel) 2021;8:343. [PMID: 33925356 DOI: 10.3390/children8050343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Roberts CM, Addante SM, Baudino MN, Edwards CS, Gamwell KL, Jacobs NJ, Tung J, Grunow JE, Mullins LL, Chaney JM. Stigma Moderates the Relation Between Peer Victimization, Thwarted Belongingness, and Depressive Symptoms in Youth with Inflammatory Bowel Disease. J Pediatr Nurs 2021;59:137-42. [PMID: 33878539 DOI: 10.1016/j.pedn.2021.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Mo A, Nagpal S, Gettler K, Haritunians T, Giri M, Haberman Y, Karns R, Prince J, Arafat D, Hsu N, Chuang L, Argmann C, Kasarskis A, Suarez-farinas M, Gotman N, Mengesha E, Venkateswaran S, Rufo PA, Baker SS, Sauer CG, Markowitz J, Pfefferkorn MD, Rosh JR, Boyle BM, Mack DR, Baldassano RN, Shah S, Leleiko NS, Heyman MB, Griffiths AM, Patel AS, Noe JD, Thomas SD, Aronow BJ, Walters TD, Mcgovern DPB, Hyams JS, Kugathasan S, Cho JH, Denson LA, Gibson G. Stratification of Risk of Progression to Colectomy in Ulcerative Colitis using Measured and Predicted Gene Expression.. [DOI: 10.1101/2021.04.02.438187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel JF, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A; International Organization for the Study of IBD. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology 2021;160:1570-83. [PMID: 33359090 DOI: 10.1053/j.gastro.2020.12.031] [Cited by in Crossref: 402] [Cited by in F6Publishing: 391] [Article Influence: 201.0] [Reference Citation Analysis]
42 Jabandziev P, Kakisaka T, Bohosova J, Pinkasova T, Kunovsky L, Slaby O, Goel A. MicroRNAs in Colon Tissue of Pediatric Ulcerative Pancolitis Patients Allow Detection and Prognostic Stratification. J Clin Med 2021;10:1325. [PMID: 33806966 DOI: 10.3390/jcm10061325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Coelho T, Sonnenberg-Riethmacher E, Gao Y, Mossotto E, Khojanazarov A, Griffin A, Mukanova S, Ashimkhanova A, Haggarty R, Borissenko A, Ashton JJ, Stafford IS, Batra A, Afzal NA, Stanton MP, Vadgama B, Adrisova K, Beattie RM, Williams AP, Ennis S, Riethmacher D. Expression profile of the matricellular protein periostin in paediatric inflammatory bowel disease. Sci Rep 2021;11:6194. [PMID: 33737520 DOI: 10.1038/s41598-021-85096-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
44 Fitzgerald RS, Sanderson IR, Claesson MJ. Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome. Microb Ecol 2021. [PMID: 33666710 DOI: 10.1007/s00248-021-01697-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Roberts CM, Baudino MN, Gamwell KL, Edwards CS, Traino KA, Tung J, Grunow JE, Jacobs NJ, Mullins LL, Chaney JM. Illness Stigma, Worry, Intrusiveness, and Depressive Symptoms in Youth With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2021;72:404-9. [PMID: 32925549 DOI: 10.1097/MPG.0000000000002939] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
46 Baudino MN, Perez MN, Roberts CM, Edwards CS, Gamwell KL, Keirns NG, Tung J, Jacobs NJ, Grunow JE, Mullins LL, Chaney JM. Stigma by Association: Parent Stigma and Youth Adjustment in Inflammatory Bowel Disease. J Pediatr Psychol 2021;46:27-35. [PMID: 33120420 DOI: 10.1093/jpepsy/jsaa083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
47 Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengießer K, Kienle P, Langhorst J, Lügering A, Schreiber S, Stallmach A, Stein J, Sturm A, Teich N, Siegmund B; Collaborators:. Aktualisierte S3-Leitlinie Colitis ulcerosa – Living Guideline. Z Gastroenterol 2020;58:e241-326. [PMID: 33260237 DOI: 10.1055/a-1296-3444] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
48 Roberts CM, Gamwell KL, Baudino MN, Grunow JE, Jacobs NJ, Tung J, Gillaspy SR, Hommel KA, Mullins LL, Chaney JM. The Contributions of Illness Stigma, Health Communication Difficulties, and Thwarted Belongingness to Depressive Symptoms in Youth with Inflammatory Bowel Disease. J Pediatr Psychol 2020;45:81-90. [PMID: 31633787 DOI: 10.1093/jpepsy/jsz084] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
49 Dhingani N, Guo C, Pan J, Li Q, Warner N, Jardine S, Leung G, Kotlarz D, Gonzaga-Jauregui C, Klein C, Snapper SB, Navas-López VM, Muise AM. The E3 ubiquitin ligase UBR5 interacts with TTC7A and may be associated with very early onset inflammatory bowel disease. Sci Rep 2020;10:18648. [PMID: 33122718 DOI: 10.1038/s41598-020-73482-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Aardoom MA, Jongsma MME, de Vries A, Wolthoorn J, de Ridder L, Escher JC. Vedolizumab Trough Levels in Children With Anti-Tumor Necrosis Factor Refractory Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;71:501-7. [PMID: 32639455 DOI: 10.1097/MPG.0000000000002833] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
51 Grant A, MacIntyre B, Kappelman MD, Otley AR. A New Domain Structure for the IMPACT-III Health-related Quality of life Tool for Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;71:494-500. [PMID: 32960540 DOI: 10.1097/MPG.0000000000002824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Quagliariello A, Del Chierico F, Reddel S, Russo A, Onetti Muda A, D'Argenio P, Angelino G, Romeo EF, Dall'Oglio L, De Angelis P, Putignani L, All The Other Fmt Opbg Committee Collaborators. Fecal Microbiota Transplant in Two Ulcerative Colitis Pediatric Cases: Gut Microbiota and Clinical Course Correlations. Microorganisms 2020;8:E1486. [PMID: 32992653 DOI: 10.3390/microorganisms8101486] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
53 Chen Y, Huang J, Li H, Li P, Xu C. Serum exosomes derived from Hp-positive gastritis patients inhibit MCP-1 and MIP-1α expression via NLRP12-Notch signaling pathway in intestinal epithelial cells and improve DSS-induced colitis in mice. Int Immunopharmacol. 2020;88:107012. [PMID: 33182033 DOI: 10.1016/j.intimp.2020.107012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
54 Stawowczyk E, Kawalec P, Kowalska-Duplaga K, Mossakowska M. Productivity Loss Among Parents of Children With Inflammatory Bowel Diseases in Relation to Disease Activity and Patient's Quality of Life. J Pediatr Gastroenterol Nutr 2020;71:340-5. [PMID: 32459743 DOI: 10.1097/MPG.0000000000002801] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Martin NG, Roberts AJ, Evans HM, Bishop J, Day AS. Three-year outcomes of childhood inflammatory bowel disease in New Zealand: A population-based cohort study. JGH Open 2020;4:642-8. [PMID: 32782951 DOI: 10.1002/jgh3.12310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Rockowitz S, LeCompte N, Carmack M, Quitadamo A, Wang L, Park M, Knight D, Sexton E, Smith L, Sheidley B, Field M, Holm IA, Brownstein CA, Agrawal PB, Kornetsky S, Poduri A, Snapper SB, Beggs AH, Yu TW, Williams DA, Sliz P. Children's rare disease cohorts: an integrative research and clinical genomics initiative. NPJ Genom Med 2020;5:29. [PMID: 32655885 DOI: 10.1038/s41525-020-0137-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
57 Adeniyi OF Sr, Odeghe E, Olatona FA, Lawal M, Onywekwelu VI, Akinbolagbe YO, Ikobah JM. Inflammatory Bowel Disease in Children: Experience and Constraints in a Resource-limited Setting. Cureus 2020;12:e7848. [PMID: 32483499 DOI: 10.7759/cureus.7848] [Reference Citation Analysis]
58 Baudino MN, Gamwell KL, Roberts CM, Grunow JE, Jacobs NJ, Gillaspy SR, Edwards CS, Mullins LL, Chaney JM. Disease Severity and Depressive Symptoms in Adolescents With Inflammatory Bowel Disease: The Mediating Role of Parent and Youth Illness Uncertainty. J Pediatr Psychol 2019;44:490-8. [PMID: 30551150 DOI: 10.1093/jpepsy/jsy091] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
59 van Hoeve K, Hoffman I, D'Hoore A, Ferrante M, Vermeire S. Long-term outcome of immunomodulator use in pediatric patients with inflammatory bowel disease. Dig Liver Dis 2020;52:164-72. [PMID: 31640916 DOI: 10.1016/j.dld.2019.09.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
60 Bramuzzo M, De Carlo C, Arrigo S, Pavanello PM, Canaletti C, Giudici F, Agrusti A, Martelossi S, Di Leo G, Barbi E. Parental Psychological Factors and Quality of Life of Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;70:211-7. [PMID: 31978019 DOI: 10.1097/MPG.0000000000002548] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
61 Gamwell KL, Roberts CM, Espeleta HC, Baudino MN, Hommel KA, Grunow JE, Jacobs NJ, Gillaspy SR, Mullins LL, Chaney JM. Perceived stigma, illness uncertainty, and depressive symptoms in youth with inflammatory bowel disease: The moderating effect of mindfulness. Psychology, Health & Medicine 2020;25:1037-48. [DOI: 10.1080/13548506.2020.1714062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
62 Karaskova E, Veghova-velganova M, Geryk M. Giant post-inflammatory polyposis in a child with ulcerative colitis: A case report. International Journal of Surgery Case Reports 2020;77:249-251. [DOI: 10.1016/j.ijscr.2020.11.013] [Reference Citation Analysis]
63 Keller K. Medikamentöse Therapie der CED bei Kindern und Jugendlichen. Chronisch-entzündliche Darmerkrankungen 2020. [DOI: 10.1007/978-3-662-59104-8_28] [Reference Citation Analysis]
64 Kelay A, Tullie L, Stanton M. Surgery and paediatric inflammatory bowel disease. Transl Pediatr 2019;8:436-48. [PMID: 31993358 DOI: 10.21037/tp.2019.09.01] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Cousin C, Bevilacqua C, Roman C, Roquelaure B, Loundou A, Baumstarck K, Fabre A. MICI-MINOTS: Linguistic and metric validation of a pediatric questionnaire on knowledge about inflammatory bowel disease. Arch Pediatr. 2020;27:110-116. [PMID: 31796231 DOI: 10.1016/j.arcped.2019.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
66 Moses J, Lambert-Jenkins K, Momotaz H, Sattar A, Debanne SM, Splawski J, Sferra TJ. Time to antibody detection and associated factors for presence of anti-drug antibodies in pediatric inflammatory bowel disease patients treated with anti-TNF therapy. Eur J Gastroenterol Hepatol 2019;31:1228-33. [PMID: 31498282 DOI: 10.1097/MEG.0000000000001538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
67 De Carlo C, Bramuzzo M, Canaletti C, Udina C, Cozzi G, Pavanello PM, Rampado S, Martelossi S, Giudici F, Di Leo G, Barbi E. The Role of Distress and Pain Catastrophizing on the Health-related Quality of Life of Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;69:e99-e104. [PMID: 31335840 DOI: 10.1097/MPG.0000000000002447] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
68 Carmody JK, Plevinsky J, Peugh JL, Denson LA, Hyams JS, Lobato D, LeLeiko NS, Hommel KA. Longitudinal non-adherence predicts treatment escalation in paediatric ulcerative colitis. Aliment Pharmacol Ther 2019;50:911-8. [PMID: 31373712 DOI: 10.1111/apt.15445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
69 Karaskova E, Volejnikova J, Holub D, Velganova-Veghova M, Spenerova M, Mihal V, Pospisilova D. Changes in serum hepcidin levels in children with inflammatory bowel disease during anti-inflammatory treatment. J Paediatr Child Health 2020;56:276-82. [PMID: 31411363 DOI: 10.1111/jpc.14593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
70 van Hoeve K, Dreesen E, Hoffman I, Van Assche G, Ferrante M, Gils A, Vermeire S. Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease. Therapeutic Drug Monitoring 2019;41:317-24. [DOI: 10.1097/ftd.0000000000000601] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
71 van Hoeve K, Dreesen E, Hoffman I, Van Assche G, Ferrante M, Gils A, Vermeire S. Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;68:847-53. [PMID: 30633108 DOI: 10.1097/MPG.0000000000002265] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
72 Walker R, Kammermeier J, Vora R, Mutalib M. Azathioprine dosing and metabolite measurement in pediatric inflammatory bowel disease: does one size fit all? Ann Gastroenterol 2019;32:387-91. [PMID: 31263361 DOI: 10.20524/aog.2019.0381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Roberts CM, Gamwell KL, Baudino MN, Perez MN, Delozier AM, Sharkey CM, Grant DM, Grunow JE, Jacobs NJ, Tung J, Gillaspy SR, Mullins LL, Chaney JM. Youth and Parent Illness Appraisals and Adjustment in Pediatric Inflammatory Bowel Disease. J Dev Phys Disabil 2019;31:777-90. [DOI: 10.1007/s10882-019-09678-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
74 Daniluk U, Daniluk J, Krasnodebska M, Lotowska JM, Sobaniec-Lotowska ME, Lebensztejn DM. The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease. Adv Med Sci 2019;64:9-14. [PMID: 30237086 DOI: 10.1016/j.advms.2018.08.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
75 Jarasvaraparn C, Zlomke K, Vann NC, Wang B, Crissinger KD, Gremse DA. The Relationship Between Sleep Disturbance and Disease Activity in Pediatric Patients With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2019;68:237-43. [PMID: 30256267 DOI: 10.1097/MPG.0000000000002156] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
76 Carman N, Tomalty D, Church PC, Mack DR, Benchimol EI, Otley AR, Jacobson K, Huynh HQ, DeBruyn JC, El-Matary W, Sherlock M, Van Limbergen J, Griffiths AM, Walters TD; Canadian Children Inflammatory Bowel Disease Network: A Joint Partnership of Canadian Institutes of Health Research and the Children with Intestinal and Liver Disorders Foundation. Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn's disease. Gastrointest Endosc 2019;89:364-72. [PMID: 30273592 DOI: 10.1016/j.gie.2018.09.025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
77 Whaley KG, Rosen MJ. Contemporary Medical Management of Acute Severe Ulcerative Colitis. Inflamm Bowel Dis 2019;25:56-66. [PMID: 29889235 DOI: 10.1093/ibd/izy208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
78 van Hoeve K, Dreesen E, Hoffman I, Van Assche G, Ferrante M, Gils A, Vermeire S. Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease. J Crohns Colitis 2018;12:1316-25. [PMID: 30239644 DOI: 10.1093/ecco-jcc/jjy111] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
79 Lucia Casadonte CJ, Brown J, Strople J, Neighbors K, Fei L, Alonso EM. Low Insulin-like Growth Factor-1 Influences Fatigue and Quality of Life in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2018;67:616-21. [PMID: 29901552 DOI: 10.1097/MPG.0000000000002057] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
80 Tan Tanny SP, Yoo M, Hutson JM, Langer JC, King SK. Current surgical practice in pediatric ulcerative colitis: A systematic review. J Pediatr Surg 2019;54:1324-30. [PMID: 30241963 DOI: 10.1016/j.jpedsurg.2018.08.050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
81 El Amrousy DM, Hassan S, El-Ashry H, Yousef M, Sharshar R. Pulmonary Function Tests Abnormalities in Children With Inflammatory Bowel Disease: Is It Common? J Pediatr Gastroenterol Nutr 2018;67:346-50. [PMID: 29620595 DOI: 10.1097/MPG.0000000000001989] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
82 Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos KH, Croft N, Navas-López VM, Wilson DC, Lawrence S, Russell RK. Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis-An Evidence-based Consensus Guideline From the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67:292-310. [PMID: 30044358 DOI: 10.1097/MPG.0000000000002036] [Cited by in Crossref: 107] [Cited by in F6Publishing: 87] [Article Influence: 21.4] [Reference Citation Analysis]
83 Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos K, Croft N, Navas-López V, Wilson DC, Lawrence S, Russell RK. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018;67:257-91. [PMID: 30044357 DOI: 10.1097/MPG.0000000000002035] [Cited by in Crossref: 188] [Cited by in F6Publishing: 157] [Article Influence: 37.6] [Reference Citation Analysis]
84 Veereman G, Hauser B, De Greef E, Devreker T, Huysentruyt K, Lemmens R, Vandenplas Y. Reflections on treatment of IBD in children and adolescents. Immunopharmacol Immunotoxicol 2018;40:461-4. [PMID: 30040512 DOI: 10.1080/08923973.2018.1474922] [Reference Citation Analysis]
85 Wang XQ, Xiao Y, Xu X, Yu Y, Shan CY, Guo Y, Gong L, Zhou T, Gao SS, Yuan YZ, Wang XJ, Xu CD. Study of disease phenotype and its association with prognosis of paediatric inflammatory bowel disease in China. BMC Pediatr. 2018;18:229. [PMID: 30001197 DOI: 10.1186/s12887-018-1212-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
86 Carreon SA, Bugno LT, Wojtowicz AA, Greenley RN. School Functioning in Adolescents With Inflammatory Bowel Diseases: An Examination of Disease and Demographic Correlates. Inflamm Bowel Dis 2018;24:1624-31. [PMID: 29718311 DOI: 10.1093/ibd/izy026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
87 Karaskova E, Volejnikova J, Holub D, Velganova‐veghova M, Sulovska L, Mihal V, Horvathova M, Pospisilova D. Hepcidin in newly diagnosed inflammatory bowel disease in children. J Paediatr Child Health 2018;54:1362-7. [DOI: 10.1111/jpc.14093] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
88 Auth MK, Bunn SK, Protheroe AL, Williams LJ, Fell JM, Muhammed R, Croft NM, Beattie RM, Willmott A, Spray C, Vadamalayan B, Rodrigues A, Puntis J, Pigott AJ, Wilson DC, Mitton S, Furman M, Charlton C, Chong SKF, Russell RK; BSPGHAN IBD working group, BSPGHAN IBD site leads. Improved Medical Treatment and Surgical Surveillance of Children and Adolescents with Ulcerative Colitis in the United Kingdom. Inflamm Bowel Dis 2018;24:1520-30. [PMID: 29668982 DOI: 10.1093/ibd/izy042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
89 Gamwell KL, Baudino MN, Bakula DM, Sharkey CM, Roberts CM, Grunow JE, Jacobs NJ, Gillaspy SR, Mullins LL, Chaney JM. Perceived Illness Stigma, Thwarted Belongingness, and Depressive Symptoms in Youth With Inflammatory Bowel Disease (IBD). Inflamm Bowel Dis 2018;24:960-5. [PMID: 29688469 DOI: 10.1093/ibd/izy011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
90 Rinawi F, Assa A, Hartman C, Mozer Glassberg Y, Nachmias Friedler V, Rosenbach Y, Silbermintz A, Zevit N, Shamir R. Long-term Extent Change of Pediatric-Onset Ulcerative Colitis. J Clin Gastroenterol 2018;52:326-32. [PMID: 28067753 DOI: 10.1097/MCG.0000000000000741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
91 Akintimehin AO, O'Neill RS, Ring C, Raftery T, Hussey S. Outcomes of a National Cohort of Children with Acute Severe Ulcerative Colitis. Front Pediatr 2018;6:48. [PMID: 29568735 DOI: 10.3389/fped.2018.00048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
92 Diederen K, Gerritsma JJ, Koot BGP, Tabbers MM, Benninga MA, Kindermann A. Do Children and Adolescents With Inflammatory Bowel Disease Complete Clinical Disease Indices Similar to Physicians? J Pediatr Gastroenterol Nutr 2018;66:410-6. [PMID: 28832362 DOI: 10.1097/MPG.0000000000001712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
93 Cohen S, Martinez-vinson C, Aloi M, Turner D, Assa A, de Ridder L, Wolters VM, de Meij T, Alvisi P, Bronsky J, Kopylov U. Cytomegalovirus Infection in Pediatric Severe Ulcerative Colitis—A Multicenter Study from the Pediatric Inflammatory Bowel Disease Porto Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Pediatric Infectious Disease Journal 2018;37:197-201. [DOI: 10.1097/inf.0000000000001724] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
94 Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MKH, Elawad M, Fell JME, Beattie RM, Loganathan S, Torrente F, Morris MA, Charlton C, Croft NM, Rodrigues A, Furman M, Vadamalayan B, Jenkins H, Zamvar V, Mitton SG, Chong S, Cosgrove M, Akobeng A, Wilson DC, Russell RK. Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response. J Pediatr Gastroenterol Nutr 2018;66:274-80. [PMID: 29356768 DOI: 10.1097/MPG.0000000000001679] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
95 Assa A, Rinawi F, Shamir R. The Long-Term Predictive Properties of the Paris Classification in Paediatric Inflammatory Bowel Disease Patients. J Crohns Colitis 2018;12:39-47. [PMID: 28961726 DOI: 10.1093/ecco-jcc/jjx125] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
96 Siow VS, Bhatt R, Mollen KP. Management of acute severe ulcerative colitis in children. Semin Pediatr Surg. 2017;26:367-372. [PMID: 29126505 DOI: 10.1053/j.sempedsurg.2017.10.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
97 Yu YR, Rodriguez JR. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Semin Pediatr Surg. 2017;26:349-355. [PMID: 29126502 DOI: 10.1053/j.sempedsurg.2017.10.003] [Cited by in Crossref: 115] [Cited by in F6Publishing: 124] [Article Influence: 19.2] [Reference Citation Analysis]
98 Rinawi F, Assa A, Eliakim R, Mozer-Glassberg Y, Nachmias-Friedler V, Niv Y, Rosenbach Y, Silbermintz A, Zevit N, Shamir R. Risk of Colectomy in Patients With Pediatric-onset Ulcerative Colitis. J Pediatr Gastroenterol Nutr 2017;65:410-5. [PMID: 28207474 DOI: 10.1097/MPG.0000000000001545] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
99 Nir O, Rinawi F, Amarilyo G, Harel L, Shamir R, Assa A. Phenotypic Features and Longterm Outcomes of Pediatric Inflammatory Bowel Disease Patients with Arthritis and Arthralgia. J Rheumatol 2017;44:1636-43. [PMID: 28864649 DOI: 10.3899/jrheum.170168] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
100 Rinawi F, Assa A, Eliakim R, Mozer Glassberg Y, Nachmias Friedler V, Niv Y, Rosenbach Y, Silbermintz A, Zevit N, Shamir R. Predictors of pouchitis after ileal pouch-anal anastomosis in pediatric-onset ulcerative colitis. Eur J Gastroenterol Hepatol 2017;29:1079-85. [PMID: 28542114 DOI: 10.1097/MEG.0000000000000914] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
101 Rinawi F, Assa A, Bashir H, Peleg S, Shamir R. Clinical and Phenotypic Differences in Inflammatory Bowel Disease Among Arab and Jewish Children in Israel. Dig Dis Sci 2017;62:2095-101. [PMID: 28547648 DOI: 10.1007/s10620-017-4623-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
102 Osiecki M, Dądalski M, Oracz G, Kierkuś J. A clinical characteristic of paediatric ulcerative colitis patients qualified for a Cyclosporin A therapy. Pediatria Polska 2017;92:378-381. [DOI: 10.1016/j.pepo.2017.04.005] [Reference Citation Analysis]
103 Syed S, Kugathasan S, Kumar A, Prince J, Schoen BT, McCracken C, Ziegler TR, Suchdev PS. Use of Reticulocyte Hemoglobin Content in the Assessment of Iron Deficiency in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2017;64:713-20. [PMID: 27429427 DOI: 10.1097/MPG.0000000000001335] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
104 Yamamoto-furusho J, Bosques-padilla F, Daffra P, De Paula J, Etchevers J, Galiano M, Ibañez P, Juliao F, Kotze P, Marroquín de la Garza J, Monreal Robles R, Rocha J, Steinwurz F, Vázquez-frías R, Veitia G, Zaltman C. Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part). Revista de Gastroenterología de México (English Edition) 2017;82:134-155. [DOI: 10.1016/j.rgmxen.2016.07.004] [Reference Citation Analysis]
105 Maddux M, Ricks S, Delurgio S, Hommel K. A Pilot Study Evaluating the Impact of an Adherence-promoting Intervention Among Nonadherent Youth With Inflammatory Bowel Disease. J Pediatr Nurs 2017;35:72-7. [PMID: 28728772 DOI: 10.1016/j.pedn.2017.03.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
106 Yamamoto-Furusho JK, Bosques-Padilla F, Daffra P, De Paula JA, Etchevers J, Galiano MT, Ibañez P, Juliao F, Kotze PG, Marroquín de la Garza JM, Monreal Robles R, Rocha JL, Steinwurz F, Vázquez-Frías R, Veitia G, Zaltman C. Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part). Rev Gastroenterol Mex 2017;82:134-55. [PMID: 28318706 DOI: 10.1016/j.rgmx.2016.07.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
107 Rolandsdotter H, Marits P, Sundin U, Wikström AC, Fagerberg UL, Finkel Y, Eberhardson M. Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on  Maintenance Treatment. Int J Mol Sci 2017;18:E575. [PMID: 28272355 DOI: 10.3390/ijms18030575] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
108 Marcovitch L, Nissan A, Mack D, Otley A, Hussey S, Mclean B, Lewis M, Croft N, Barakat FM, Griffiths AM, Turner D. Item Generation and Reduction Toward Developing a Patient-reported Outcome for Pediatric Ulcerative Colitis (TUMMY-UC). J Pediatr Gastroenterol Nutr 2017;64:373-7. [PMID: 27159210 DOI: 10.1097/MPG.0000000000001259] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
109 Werner H, Landolt MA, Buehr P, Koller R, Nydegger A, Spalinger J, Heyland K, Schibli S, Braegger CP; The Swiss IBD Cohort Study Group. Changes in health-related quality of life over a 1-year follow-up period in children with inflammatory bowel disease. Qual Life Res 2017;26:1617-26. [DOI: 10.1007/s11136-017-1513-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
110 Radin M, Sciascia S, Roccatello D, Cuadrado MJ. Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review. BioDrugs. 2017;31:37-49. [PMID: 28035633 DOI: 10.1007/s40259-016-0206-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
111 Adler J, Colletti RB, Crandall WV, Margolis PA. Quality Improvement in Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_56] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
112 Kaplan JL, Winter HS. Treatment of Acute Severe Ulcerative Colitis. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_37] [Reference Citation Analysis]
113 Turner D, Ledder O. Clinical Indices for Pediatric Inflammatory Bowel Disease Research. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_46] [Reference Citation Analysis]
114 Lee WS, Ng RT, Chan KW, Lau YL. Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort. World J Gastroenterol 2016; 22(48): 10653-10662 [PMID: 28082818 DOI: 10.3748/wjg.v22.i48.10653] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
115 Kapoor A, Bhatia V, Sibal A. Pediatric inflammatory bowel disease. Indian Pediatr 2016;53:993-1002. [DOI: 10.1007/s13312-016-0975-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
116 Dharmaraj R, Dasgupta M, Simpson P, Noe J. Predictors of Pouchitis After Ileal Pouch-Anal Anastomosis in Children. J Pediatr Gastroenterol Nutr 2016;63:e58-62. [PMID: 27243421 DOI: 10.1097/MPG.0000000000001279] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
117 Giannakopoulos G, Chouliaras G, Margoni D, Korlou S, Hantzara V, Panayotou I, Roma E, Liakopoulou M, Anagnostopoulos DC. Stressful life events and psychosocial correlates of pediatric inflammatory bowel disease activity. World J Psychiatr 2016; 6(3): 322-328 [PMID: 27679771 DOI: 10.5498/wjp.v6.i3.322] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
118 Reigada LC, Satpute A, Hoogendoorn CJ, Cohen BH, Lai J, Bao R, Dubinsky MC, Benkov KJ. Patient-reported Anxiety: A Possible Predictor of Pediatric Inflammatory Bowel Disease Health Care Use. Inflamm Bowel Dis 2016;22:2127-33. [PMID: 27482980 DOI: 10.1097/MIB.0000000000000864] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
119 Choshen S, Finnamore H, Auth MK, Bdolah-Abram T, Shteyer E, Mack D, Hyams J, Leleiko N, Griffiths A, Turner D. Corticosteroid Dosing in Pediatric Acute Severe Ulcerative Colitis: A Propensity Score Analysis. J Pediatr Gastroenterol Nutr 2016;63:58-64. [PMID: 26756874 DOI: 10.1097/MPG.0000000000001079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
120 Vora R, Finnamore HE, Crook K, Baillie C, Whittle E, Krishnamurthy B, Venkatesh K, Auth MK. Clinical Experience of Use of High-dose Intravenous Methylprednisolone in Children With Acute Moderate to Severe Colitis. J Pediatr Gastroenterol Nutr 2016;63:51-7. [PMID: 26756873 DOI: 10.1097/MPG.0000000000001080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
121 Kolho K. Assessment of disease activity in pediatric ulcerative colitis. Expert Review of Gastroenterology & Hepatology 2016;10:1127-34. [DOI: 10.1080/17474124.2016.1185364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
122 Callias C, Ezri J, Marques-vidal PM, Nydegger A. Assessment of skinfold thickness equations in estimating body composition in children with inflammatory bowel disease: Anthropometry in paediatric inflammatory bowel disease. Journal of Paediatrics and Child Health 2016;52:547-55. [DOI: 10.1111/jpc.13146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
123 Jelenova D, Prasko J, Ociskova M, Latalova K, Karaskova E, Hruby R, Kamaradova D, Mihal V. Quality of life and parental styles assessed by adolescents suffering from inflammatory bowel diseases and their parents. Neuropsychiatr Dis Treat 2016;12:665-72. [PMID: 27042077 DOI: 10.2147/NDT.S104260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
124 Radillo O, Pascolo L, Martelossi S, Dal Bo S, Ventura A. Fecal Calprotectin: Diagnostic Accuracy of the Immunochromatographic CalFast Assay in a Pediatric Population. J Clin Lab Anal 2016;30:500-5. [PMID: 26879689 DOI: 10.1002/jcla.21886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
125 Sieczkowska J, Jarzębicka D, Banaszkiewicz A, Plocek A, Gawronska A, Toporowska-Kowalska E, Oracz G, Meglicka M, Kierkus J. Switching Between Infliximab Originator and Biosimilar in Paediatric Patients with Inflammatory Bowel Disease. Preliminary Observations. J Crohns Colitis 2016;10:127-32. [PMID: 26721942 DOI: 10.1093/ecco-jcc/jjv233] [Cited by in Crossref: 101] [Cited by in F6Publishing: 90] [Article Influence: 14.4] [Reference Citation Analysis]
126 Higuchi LM, Regan BP, Bousvaros A. Ulcerative Colitis. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2016. [DOI: 10.1007/978-3-319-17169-2_30] [Reference Citation Analysis]
127 Osiecki M, Woźniak M, Kierkuś J. Zastosowanie cyklosporyny A we wrzodziejącym zapaleniu jelita grubego i autoimmunizacyjnym zapaleniu wątroby u dzieci. Pediatria Polska 2016;91:46-51. [DOI: 10.1016/j.pepo.2015.09.001] [Reference Citation Analysis]
128 Valentino PL, Feldman BM, Walters TD, Griffiths AM, Ling SC, Pullenayegum EM, Kamath BM. Abnormal Liver Biochemistry Is Common in Pediatric Inflammatory Bowel Disease: Prevalence and Associations. Inflamm Bowel Dis 2015;21:2848-56. [PMID: 26273817 DOI: 10.1097/MIB.0000000000000558] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
129 Huth K, Benchimol EI, Aglipay M, Mack DR. Strategies to Improve Influenza Vaccination in Pediatric Inflammatory Bowel Disease Through Education and Access. Inflamm Bowel Dis 2015;21:1761-8. [PMID: 26199989 DOI: 10.1097/MIB.0000000000000425] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
130 Koutsochristou V, Zellos A, Dimakou K, Panayotou I, Siahanidou S, Roma-Giannikou E, Tsami A. Dental Caries and Periodontal Disease in Children and Adolescents with Inflammatory Bowel Disease: A Case-Control Study. Inflamm Bowel Dis 2015;21:1839-46. [PMID: 25985243 DOI: 10.1097/MIB.0000000000000452] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
131 Lazzerini M, Martelossi S, Magazzù G, Pellegrino S, Lucanto MC, Barabino A, Calvi A, Arrigo S, Lionetti P, Lorusso M, Mangiantini F, Fontana M, Zuin G, Palla G, Maggiore G, Bramuzzo M, Pellegrin MC, Maschio M, Villanacci V, Manenti S, Decorti G, De Iudicibus S, Paparazzo R, Montico M, Ventura A. Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial. Inflamm Bowel Dis 2015;21:1739-49. [PMID: 26185909 DOI: 10.1097/MIB.0000000000000437] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
132 Schechter A, Griffiths C, Gana JC, Shaoul R, Shamir R, Shteyer E, Bdolah-Abram T, Ledder O, Turner D. Early endoscopic, laboratory and clinical predictors of poor disease course in paediatric ulcerative colitis. Gut 2015;64:580-8. [PMID: 24848266 DOI: 10.1136/gutjnl-2014-306999] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
133 Ruemmele FM, Hyams JS, Otley A, Griffiths A, Kolho KL, Dias JA, Levine A, Escher JC, Taminiau J, Veres G, Colombel JF, Vermeire S, Wilson DC, Turner D. Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee. Gut 2015;64:438-46. [PMID: 24821616 DOI: 10.1136/gutjnl-2014-307008] [Cited by in Crossref: 57] [Cited by in F6Publishing: 38] [Article Influence: 7.1] [Reference Citation Analysis]
134 Dotson JL, Crandall WV, Zhang P, Forrest CB, Bailey LC, Colletti RB, Kappelman MD. Feasibility and validity of the pediatric ulcerative colitis activity index in routine clinical practice. J Pediatr Gastroenterol Nutr 2015;60:200-4. [PMID: 25221935 DOI: 10.1097/MPG.0000000000000568] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
135 Sachar DB; Biomarkers Task Force of the IOIBD. Role of biomarkers in the study and management of inflammatory bowel disease: a "nonsystematic" review. Inflamm Bowel Dis 2014;20:2511-8. [PMID: 25222663 DOI: 10.1097/MIB.0000000000000135] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
136 Oh SH, Kim KM. Current issues of pediatric inflammatory bowel disease in Korea. Korean J Pediatr. 2014;57:465-471. [PMID: 25550700 DOI: 10.3345/kjp.2014.57.11.465] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
137 Turner D, Levine A, Kolho KL, Shaoul R, Ledder O. Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report. J Crohns Colitis 2014;8:1464-70. [PMID: 24958064 DOI: 10.1016/j.crohns.2014.05.010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
138 Sieczkowska J, Dądalski M, Jarzębicka D, Kierkuś J. Aktualne wytyczne klasyfikacji i diagnostyki nieswoistych zapaleń jelit u dzieci. Pediatria Polska 2014;89:436-443. [DOI: 10.1016/j.pepo.2014.07.001] [Reference Citation Analysis]
139 Schwenk HT, Lightdale JR, Arnold JH, Goldmann DA, Weitzman ER. Coping with college and inflammatory bowel disease: implications for clinical guidance and support. Inflamm Bowel Dis 2014;20:1618-27. [PMID: 25105948 DOI: 10.1097/MIB.0000000000000124] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
140 Gomollón F, García-López S, Sicilia B, Gisbert JP, Hinojosa J; en representació del Grupo Espa˜nol de Trabajode Enfermedad de Crohn y Colitis Ulcerosa or Spanish Group for Working on Crohn’sDisease and Ulcerative Colitis (GETECCU). [Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU]. Gastroenterol Hepatol 2013;36:e1-47. [PMID: 24215088 DOI: 10.1016/j.gastrohep.2012.11.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
141 Lee GJ, Dotson JL, Kappelman MD, King E, Pratt JM, Colletti RB, Bistrick S, Burkam JL, Crandall WV; ImproveCareNow Network. Seasonality and pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014;59:25-8. [PMID: 24614123 DOI: 10.1097/MPG.0000000000000362] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
142 Ziech ML, Hummel TZ, Smets AM, Nievelstein RA, Lavini C, Caan MW, Nederveen AJ, Roelofs JJ, Bipat S, Benninga MA, Kindermann A, Stoker J. Accuracy of abdominal ultrasound and MRI for detection of Crohn disease and ulcerative colitis in children. Pediatr Radiol. 2014;44:1370-1378. [PMID: 24903659 DOI: 10.1007/s00247-014-3010-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
143 Sun H, Vesely R, Taminiau J, Szitanyi P, Papadopoulos EJ, Isaac M, Klein A, Uzu S, Griebel D, Mulberg AE; International Inflammatory Bowel Disease Working Group. Steps toward harmonization for clinical development of medicines in pediatric ulcerative colitis-a global scientific discussion, part 1: efficacy endpoints and disease outcome assessments. J Pediatr Gastroenterol Nutr 2014;58:679-83. [PMID: 24866781 DOI: 10.1097/MPG.0000000000000306] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
144 Stenke E, Hussey S. Ulcerative colitis: management in adults, children and young people (NICE Clinical Guideline CG166). Arch Dis Child Educ Pract Ed. 2014;99:194-197. [PMID: 24821990 DOI: 10.1136/archdischild-2013-305512] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
145 Civitelli F, Di Nardo G, Oliva S, Nuti F, Ferrari F, Dilillo A, Viola F, Pallotta N, Cucchiara S, Aloi M. Ultrasonography of the colon in pediatric ulcerative colitis: a prospective, blind, comparative study with colonoscopy. J Pediatr 2014;165:78-84.e2. [PMID: 24725581 DOI: 10.1016/j.jpeds.2014.02.055] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
146 Gray FL, Turner CG, Zurakowski D, Bousvaros A, Linden BC, Shamberger RC, Lillehei CW. Predictive value of the Pediatric Ulcerative Colitis Activity Index in the surgical management of ulcerative colitis. J Pediatr Surg. 2013;48:1540-1545. [PMID: 23895969 DOI: 10.1016/j.jpedsurg.2013.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
147 Urlep D, Trop TK, Blagus R, Orel R. Incidence and phenotypic characteristics of pediatric IBD in northeastern Slovenia, 2002-2010. J Pediatr Gastroenterol Nutr 2014;58:325-32. [PMID: 24135984 DOI: 10.1097/MPG.0000000000000207] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
148 Bradley GM, Oliva-hemker M. Infliximab for the treatment of pediatric ulcerative colitis. Expert Review of Gastroenterology & Hepatology 2014;6:659-65. [DOI: 10.1586/egh.12.53] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
149 Albenberg L, Baldassano RN, Kelsen J. Pediatric Issues in Treating Ulcerative Colitis. Medical Therapy of Ulcerative Colitis 2014. [DOI: 10.1007/978-1-4939-1677-1_25] [Reference Citation Analysis]
150 Ryan JL, Mellon MW, Junger KW, Hente EA, Denson LA, Saeed SA, Hommel KA. The clinical utility of health-related quality of life screening in a pediatric inflammatory bowel disease clinic. Inflamm Bowel Dis 2013;19:2666-72. [PMID: 24051932 DOI: 10.1097/MIB.0b013e3182a82b15] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
151 Turner D, Griffiths AM, Veerman G, Johanns J, Damaraju L, Blank M, Hyams J. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab. Clin Gastroenterol Hepatol 2013;11:1460-5. [PMID: 23672831 DOI: 10.1016/j.cgh.2013.04.049] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
152 Addobbati R, Pascolo L, Di Toro N, Sebastiani GB, Martellossi S, Not T. Influence of urine volume on the assessment of intestinal permeability in affected children by multiple sugar probes. Clin Chem Lab Med 2014;52:227-35. [PMID: 24108205 DOI: 10.1515/cclm-2013-0626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
153 Van Biervliet S, Bonroy C, Vande Velde S, De Bruyne R, Van Winckel M, Peeters H, Delanghe J, Stove V, De Vos M. C-ANCA/proteinase 3-positive colitis in children: a distinctive form of inflammatory bowel disease or vasculitis with colitis as initial presentation? J Pediatr Gastroenterol Nutr 2013;57:489-92. [PMID: 23752080 DOI: 10.1097/MPG.0b013e31829d4e9e] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
154 Gomollón F, García-lópez S, Sicilia B, Gisbert JP, Hinojosa J. The GETECCU clinical guideline for the treatment of ulcerative colitis: A guideline created using GRADE methodology. Gastroenterología y Hepatología 2013;36:483.e1-483.e46. [DOI: 10.1016/j.gastrohep.2012.11.002] [Reference Citation Analysis]
155 Chouliaras G, Panayotou I, Margoni D, Mantzou E, Pervanidou P, Manios Y, Chrousos GP, Roma E. Circulating leptin and adiponectin and their relation to glucose metabolism in children with Crohn’s disease and ulcerative colitis. Pediatr Res 2013;74:420-6. [DOI: 10.1038/pr.2013.114] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
156 Russell RK, Protheroe A, Roughton M, Croft NM, Murphy MS, Spray C, Rodrigues AF, Wilson DC, Puntis J, Cosgrove M, Tamok A, Rao P, Down C, Arnott ID, Mitton SG. Contemporary outcomes for ulcerative colitis inpatients admitted to pediatric hospitals in the United Kingdom. Inflamm Bowel Dis 2013;19:1434-40. [PMID: 23624885 DOI: 10.1097/MIB.0b013e31828133d6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
157 Burri E, Beglinger C, Lehmann FS. Monitoring of therapy for inflammatory bowel disease. Digestion 2012;86 Suppl 1:1-5. [PMID: 23051719 DOI: 10.1159/000341953] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
158 Kolho KL, Turner D. Fecal calprotectin and clinical disease activity in pediatric ulcerative colitis. ISRN Gastroenterol 2013;2013:179024. [PMID: 23533791 DOI: 10.1155/2013/179024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
159 Wang XQ, Zhang Y, Xu CD, Jiang LR, Huang Y, Du HM, Wang XJ. Inflammatory bowel disease in Chinese children: a multicenter analysis over a decade from Shanghai. Inflamm Bowel Dis 2013;19:423-8. [PMID: 23340680 DOI: 10.1097/MIB.0b013e318286f9f2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 5.2] [Reference Citation Analysis]
160 Puthoor PR, de Zoeten EF. Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab. Biol Ther. 2013;3:1-14. [PMID: 24392300 DOI: 10.1007/s13554-012-0006-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
161 Zeisler B, Lerer T, Markowitz J, Mack D, Griffiths A, Bousvaros A, Keljo D, Rosh J, Evans J, Kappelman M, Otley A, Kay M, Grossman A, Saeed S, Carvalho R, Oliva-Hemker M, Faubion W, Sudel B, Pfefferkorn M, Ashai-Khan F, Leleiko N, Hyams J; Pediatric Inflammatory Bowel Disease Collaborative Research Group. Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis. J Pediatr Gastroenterol Nutr 2013;56:12-8. [PMID: 22847466 DOI: 10.1097/MPG.0b013e31826ac41a] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
162 LeLeiko NS, Lobato D, Hagin S, McQuaid E, Seifer R, Kopel SJ, Boergers J, Nassau J, Suorsa K, Shapiro J, Bancroft B. Rates and predictors of oral medication adherence in pediatric patients with IBD. Inflamm Bowel Dis 2013;19:832-9. [PMID: 23446336 DOI: 10.1097/MIB.0b013e3182802b57] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
163 Cucchiara S, Di Nardo G, Aloi M. Clinical Trials (Clinician Perspective). Pediatric Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-5061-0_42] [Reference Citation Analysis]
164 Noble A, Turner D. Clinical Indices for Pediatric Inflammatory Bowel Disease Research. Pediatric Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-5061-0_41] [Reference Citation Analysis]
165 Lee GJ, Kappelman MD, Boyle B, Colletti RB, King E, Pratt JM, Crandall WV. Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2012;55:701-6. [PMID: 22744192 DOI: 10.1097/MPG.0b013e318266241b] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
166 Gourlay DM. Colorectal considerations in pediatric patients. Surg Clin North Am 2013;93:251-72. [PMID: 23177075 DOI: 10.1016/j.suc.2012.09.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
167 Kelley-Quon LI, Jen HC, Ziring DA, Gupta N, Kirschner BS, Ferry GD, Cohen SA, Winter HS, Heyman MB, Gold BD, Shew SB. Predictors of proctocolectomy in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 2012;55:534-40. [PMID: 22684351 DOI: 10.1097/MPG.0b013e3182619d26] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
168 Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, Dias JA, Bronsky J, Braegger CP, Cucchiara S, de Ridder L, Fagerberg UL, Hussey S, Hugot JP, Kolacek S, Kolho KL, Lionetti P, Paerregaard A, Potapov A, Rintala R, Serban DE, Staiano A, Sweeny B, Veerman G, Veres G, Wilson DC, Ruemmele FM; European Crohn's and Colitis Organization, European Society for Paediatric Gastroenterology, Hepatology, and Nutrition. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr 2012;55:340-61. [PMID: 22773060 DOI: 10.1097/MPG.0b013e3182662233] [Cited by in Crossref: 275] [Cited by in F6Publishing: 285] [Article Influence: 25.0] [Reference Citation Analysis]
169 Rufo PA, Denson LA, Sylvester FA, Szigethy E, Sathya P, Lu Y, Wahbeh GT, Sena LM, Faubion WA. Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations. J Pediatr Gastroenterol Nutr 2012;55:93-108. [PMID: 22516861 DOI: 10.1097/MPG.0b013e31825959b8] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 7.3] [Reference Citation Analysis]
170 Papa E, Docktor M, Smillie C, Weber S, Preheim SP, Gevers D, Giannoukos G, Ciulla D, Tabbaa D, Ingram J, Schauer DB, Ward DV, Korzenik JR, Xavier RJ, Bousvaros A, Alm EJ. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One. 2012;7:e39242. [PMID: 22768065 DOI: 10.1371/journal.pone.0039242] [Cited by in Crossref: 203] [Cited by in F6Publishing: 214] [Article Influence: 18.5] [Reference Citation Analysis]
171 Bradley GM, Oliva-Hemker M. Pediatric ulcerative colitis: current treatment approaches including role of infliximab. Biologics 2012;6:125-34. [PMID: 22740771 DOI: 10.2147/BTT.S31833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
172 Crandall WV, Margolis PA, Kappelman MD, King EC, Pratt JM, Boyle BM, Duffy LF, Grunow JE, Kim SC, Leibowitz I. Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease. Pediatrics. 2012;129:e1030-e1041. [PMID: 22412030 DOI: 10.1542/peds.2011-1700] [Cited by in Crossref: 134] [Cited by in F6Publishing: 150] [Article Influence: 12.2] [Reference Citation Analysis]
173 Turner D, Griffiths AM, Walters TD, Seah T, Markowitz J, Pfefferkorn M, Keljo D, Waxman J, Otley A, LeLeiko NS, Mack D, Hyams J, Levine A. Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis 2012;18:55-62. [PMID: 21351206 DOI: 10.1002/ibd.21649] [Cited by in Crossref: 157] [Cited by in F6Publishing: 99] [Article Influence: 14.3] [Reference Citation Analysis]
174 Lee JJ, Colman RJ, Mitchell PD, Atmadja ML, Bousvaros A, Lightdale JR. Agreement between patient- and physician-completed Pediatric Ulcerative Colitis Activity Index scores. J Pediatr Gastroenterol Nutr 2011;52:708-13. [PMID: 21593644 DOI: 10.1097/MPG.0b013e3182099018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
175 Turner D, Travis SP, Griffiths AM, Ruemmele FM, Levine A, Benchimol EI, Dubinsky M, Alex G, Baldassano RN, Langer JC, Shamberger R, Hyams JS, Cucchiara S, Bousvaros A, Escher JC, Markowitz J, Wilson DC, van Assche G, Russell RK; European Crohn's and Colitis Organization, Porto IBD Working Group, European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol 2011;106:574-88. [PMID: 21224839 DOI: 10.1038/ajg.2010.481] [Cited by in Crossref: 150] [Cited by in F6Publishing: 144] [Article Influence: 12.5] [Reference Citation Analysis]
176 De Iudicibus S, Stocco G, Martelossi S, Londero M, Ebner E, Pontillo A, Lionetti P, Barabino A, Bartoli F, Ventura A, Decorti G. Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases. J Clin Gastroenterol 2011;45:e1-7. [PMID: 20697295 DOI: 10.1097/MCG.0b013e3181e8ae93] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
177 Kappelman MD, Crandall WV, Colletti RB, Goudie A, Leibowitz IH, Duffy L, Milov DE, Kim SC, Schoen BT, Patel AS, Grunow J, Larry E, Fairbrother G, Margolis P. Short pediatric Crohn's disease activity index for quality improvement and observational research. Inflamm Bowel Dis 2011;17:112-7. [PMID: 20812330 DOI: 10.1002/ibd.21452] [Cited by in Crossref: 108] [Cited by in F6Publishing: 62] [Article Influence: 9.0] [Reference Citation Analysis]
178 Aloi M, Di Nardo G, Conte F, Mazzeo L, Cavallari N, Nuti F, Cucchiara S, Stronati L. Methotrexate in paediatric ulcerative colitis: a retrospective survey at a single tertiary referral centre. Aliment Pharmacol Ther 2010;32:1017-22. [PMID: 20937047 DOI: 10.1111/j.1365-2036.2010.04433.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
179 Kabakchiev B, Turner D, Hyams J, Mack D, Leleiko N, Crandall W, Markowitz J, Otley AR, Xu W, Hu P, Griffiths AM, Silverberg MS. Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis. PLoS One 2010;5:e13085. [PMID: 20941359 DOI: 10.1371/journal.pone.0013085] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
180 Ferguson LR, Smith BG, James BJ. Combining nutrition, food science and engineering in developing solutions to Inflammatory bowel diseases--omega-3 polyunsaturated fatty acids as an example. Food Funct. 2010;1:60-72. [PMID: 21776456 DOI: 10.1039/c0fo00057d] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
181 Turner D, Guyatt G. Reflections on the minimal important difference: research is the ultimate goal, not the anchor. Journal of Clinical Epidemiology 2010;63:806. [DOI: 10.1016/j.jclinepi.2010.01.006] [Reference Citation Analysis]
182 Turner D, Mack D, Leleiko N, Walters TD, Uusoue K, Leach ST, Day AS, Crandall W, Silverberg MS, Markowitz J, Otley AR, Keljo D, Mamula P, Kugathasan S, Hyams J, Griffiths AM. Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. Gastroenterology 2010;138:2282-91. [PMID: 20193683 DOI: 10.1053/j.gastro.2010.02.047] [Cited by in Crossref: 180] [Cited by in F6Publishing: 190] [Article Influence: 13.8] [Reference Citation Analysis]
183 Shono T, Kato M, Aoyagi Y, Haruna H, Fujii T, Kudo T, Ohtsuka Y, Shimizu T. Assessment of Growth Disturbance in Japanese Children with IBD. Int J Pediatr 2010;2010:958915. [PMID: 20454571 DOI: 10.1155/2010/958915] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
184 Turner D, Seow CH, Greenberg GR, Griffiths AM, Silverberg MS, Steinhart AH. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. Clin Gastroenterol Hepatol 2009;7:1081-8. [PMID: 19577010 DOI: 10.1016/j.cgh.2009.06.024] [Cited by in Crossref: 123] [Cited by in F6Publishing: 100] [Article Influence: 8.8] [Reference Citation Analysis]